0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiparasitics Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-12D11630
Home | Market Reports | Health| Pharmacy
Global Antiparasitics Market Research Report 2022
BUY CHAPTERS

Global Antiparasitics Market Research Report 2025

Code: QYRE-Auto-12D11630
Report
January 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antiparasitics Market Size

The global market for Antiparasitics was valued at US$ 24580 million in the year 2024 and is projected to reach a revised size of US$ 35800 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Antiparasitics Market

Antiparasitics Market

An antiparasitic drug is a substance that kills or inhibits the growth and reproduction of parasites.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiparasitics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiparasitics.
The Antiparasitics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiparasitics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiparasitics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiparasitics Market Report

Report Metric Details
Report Name Antiparasitics Market
Accounted market size in year US$ 24580 million
Forecasted market size in 2031 US$ 35800 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injectable Forms
  • Oral Forms
Segment by Application
  • Animal
  • Human
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biosynth Carbosynth, Dechra, SANPHAR, Ipca Laboratories Ltd, Zydus Lifesciences Limited, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antiparasitics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antiparasitics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antiparasitics Market growing?

Ans: The Antiparasitics Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Antiparasitics Market size in 2031?

Ans: The Antiparasitics Market size in 2031 will be US$ 35800 million.

Who are the main players in the Antiparasitics Market report?

Ans: The main players in the Antiparasitics Market are Biosynth Carbosynth, Dechra, SANPHAR, Ipca Laboratories Ltd, Zydus Lifesciences Limited, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca

What are the Application segmentation covered in the Antiparasitics Market report?

Ans: The Applications covered in the Antiparasitics Market report are Animal, Human

What are the Type segmentation covered in the Antiparasitics Market report?

Ans: The Types covered in the Antiparasitics Market report are Injectable Forms, Oral Forms

Recommended Reports

Anti-infective Markets

Pharmaceutical Therapeutics

Animal Health Diagnostics

1 Antiparasitics Market Overview
1.1 Product Definition
1.2 Antiparasitics by Type
1.2.1 Global Antiparasitics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injectable Forms
1.2.3 Oral Forms
1.3 Antiparasitics by Application
1.3.1 Global Antiparasitics Market Value by Application (2024 VS 2031)
1.3.2 Animal
1.3.3 Human
1.4 Global Antiparasitics Market Size Estimates and Forecasts
1.4.1 Global Antiparasitics Revenue 2020-2031
1.4.2 Global Antiparasitics Sales 2020-2031
1.4.3 Global Antiparasitics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antiparasitics Market Competition by Manufacturers
2.1 Global Antiparasitics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antiparasitics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antiparasitics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antiparasitics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antiparasitics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiparasitics, Product Type & Application
2.7 Global Key Manufacturers of Antiparasitics, Date of Enter into This Industry
2.8 Global Antiparasitics Market Competitive Situation and Trends
2.8.1 Global Antiparasitics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antiparasitics Players Market Share by Revenue
2.8.3 Global Antiparasitics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antiparasitics Market Scenario by Region
3.1 Global Antiparasitics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antiparasitics Sales by Region: 2020-2031
3.2.1 Global Antiparasitics Sales by Region: 2020-2025
3.2.2 Global Antiparasitics Sales by Region: 2026-2031
3.3 Global Antiparasitics Revenue by Region: 2020-2031
3.3.1 Global Antiparasitics Revenue by Region: 2020-2025
3.3.2 Global Antiparasitics Revenue by Region: 2026-2031
3.4 North America Antiparasitics Market Facts & Figures by Country
3.4.1 North America Antiparasitics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antiparasitics Sales by Country (2020-2031)
3.4.3 North America Antiparasitics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antiparasitics Market Facts & Figures by Country
3.5.1 Europe Antiparasitics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antiparasitics Sales by Country (2020-2031)
3.5.3 Europe Antiparasitics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiparasitics Market Facts & Figures by Region
3.6.1 Asia Pacific Antiparasitics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antiparasitics Sales by Region (2020-2031)
3.6.3 Asia Pacific Antiparasitics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antiparasitics Market Facts & Figures by Country
3.7.1 Latin America Antiparasitics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antiparasitics Sales by Country (2020-2031)
3.7.3 Latin America Antiparasitics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiparasitics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiparasitics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antiparasitics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antiparasitics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antiparasitics Sales by Type (2020-2031)
4.1.1 Global Antiparasitics Sales by Type (2020-2025)
4.1.2 Global Antiparasitics Sales by Type (2026-2031)
4.1.3 Global Antiparasitics Sales Market Share by Type (2020-2031)
4.2 Global Antiparasitics Revenue by Type (2020-2031)
4.2.1 Global Antiparasitics Revenue by Type (2020-2025)
4.2.2 Global Antiparasitics Revenue by Type (2026-2031)
4.2.3 Global Antiparasitics Revenue Market Share by Type (2020-2031)
4.3 Global Antiparasitics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antiparasitics Sales by Application (2020-2031)
5.1.1 Global Antiparasitics Sales by Application (2020-2025)
5.1.2 Global Antiparasitics Sales by Application (2026-2031)
5.1.3 Global Antiparasitics Sales Market Share by Application (2020-2031)
5.2 Global Antiparasitics Revenue by Application (2020-2031)
5.2.1 Global Antiparasitics Revenue by Application (2020-2025)
5.2.2 Global Antiparasitics Revenue by Application (2026-2031)
5.2.3 Global Antiparasitics Revenue Market Share by Application (2020-2031)
5.3 Global Antiparasitics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biosynth Carbosynth
6.1.1 Biosynth Carbosynth Company Information
6.1.2 Biosynth Carbosynth Description and Business Overview
6.1.3 Biosynth Carbosynth Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biosynth Carbosynth Antiparasitics Product Portfolio
6.1.5 Biosynth Carbosynth Recent Developments/Updates
6.2 Dechra
6.2.1 Dechra Company Information
6.2.2 Dechra Description and Business Overview
6.2.3 Dechra Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dechra Antiparasitics Product Portfolio
6.2.5 Dechra Recent Developments/Updates
6.3 SANPHAR
6.3.1 SANPHAR Company Information
6.3.2 SANPHAR Description and Business Overview
6.3.3 SANPHAR Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SANPHAR Antiparasitics Product Portfolio
6.3.5 SANPHAR Recent Developments/Updates
6.4 Ipca Laboratories Ltd
6.4.1 Ipca Laboratories Ltd Company Information
6.4.2 Ipca Laboratories Ltd Description and Business Overview
6.4.3 Ipca Laboratories Ltd Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ipca Laboratories Ltd Antiparasitics Product Portfolio
6.4.5 Ipca Laboratories Ltd Recent Developments/Updates
6.5 Zydus Lifesciences Limited
6.5.1 Zydus Lifesciences Limited Company Information
6.5.2 Zydus Lifesciences Limited Description and Business Overview
6.5.3 Zydus Lifesciences Limited Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Lifesciences Limited Antiparasitics Product Portfolio
6.5.5 Zydus Lifesciences Limited Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Antiparasitics Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Antiparasitics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc. Company Information
6.8.2 GlaxoSmithKline Plc. Description and Business Overview
6.8.3 GlaxoSmithKline Plc. Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline Plc. Antiparasitics Product Portfolio
6.8.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.9 Cipla Ltd
6.9.1 Cipla Ltd Company Information
6.9.2 Cipla Ltd Description and Business Overview
6.9.3 Cipla Ltd Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Ltd Antiparasitics Product Portfolio
6.9.5 Cipla Ltd Recent Developments/Updates
6.10 Ranbaxy Laboratories
6.10.1 Ranbaxy Laboratories Company Information
6.10.2 Ranbaxy Laboratories Description and Business Overview
6.10.3 Ranbaxy Laboratories Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ranbaxy Laboratories Antiparasitics Product Portfolio
6.10.5 Ranbaxy Laboratories Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Company Information
6.11.2 Novartis AG Description and Business Overview
6.11.3 Novartis AG Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis AG Antiparasitics Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Alvizia Health Care
6.12.1 Alvizia Health Care Company Information
6.12.2 Alvizia Health Care Description and Business Overview
6.12.3 Alvizia Health Care Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Alvizia Health Care Antiparasitics Product Portfolio
6.12.5 Alvizia Health Care Recent Developments/Updates
6.13 Bayer AG
6.13.1 Bayer AG Company Information
6.13.2 Bayer AG Description and Business Overview
6.13.3 Bayer AG Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bayer AG Antiparasitics Product Portfolio
6.13.5 Bayer AG Recent Developments/Updates
6.14 Arbor Pharmaceuticals Inc.
6.14.1 Arbor Pharmaceuticals Inc. Company Information
6.14.2 Arbor Pharmaceuticals Inc. Description and Business Overview
6.14.3 Arbor Pharmaceuticals Inc. Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Arbor Pharmaceuticals Inc. Antiparasitics Product Portfolio
6.14.5 Arbor Pharmaceuticals Inc. Recent Developments/Updates
6.15 Sanofi
6.15.1 Sanofi Company Information
6.15.2 Sanofi Description and Business Overview
6.15.3 Sanofi Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sanofi Antiparasitics Product Portfolio
6.15.5 Sanofi Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Company Information
6.16.2 AstraZeneca Description and Business Overview
6.16.3 AstraZeneca Antiparasitics Sales, Revenue and Gross Margin (2020-2025)
6.16.4 AstraZeneca Antiparasitics Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiparasitics Industry Chain Analysis
7.2 Antiparasitics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiparasitics Production Mode & Process Analysis
7.4 Antiparasitics Sales and Marketing
7.4.1 Antiparasitics Sales Channels
7.4.2 Antiparasitics Distributors
7.5 Antiparasitics Customer Analysis
8 Antiparasitics Market Dynamics
8.1 Antiparasitics Industry Trends
8.2 Antiparasitics Market Drivers
8.3 Antiparasitics Market Challenges
8.4 Antiparasitics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antiparasitics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antiparasitics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antiparasitics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antiparasitics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antiparasitics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antiparasitics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antiparasitics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antiparasitics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antiparasitics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antiparasitics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antiparasitics, Product Type & Application
 Table 12. Global Key Manufacturers of Antiparasitics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antiparasitics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antiparasitics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antiparasitics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antiparasitics Sales Market Share by Region (2020-2025)
 Table 19. Global Antiparasitics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antiparasitics Sales Market Share by Region (2026-2031)
 Table 21. Global Antiparasitics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antiparasitics Revenue Market Share by Region (2020-2025)
 Table 23. Global Antiparasitics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antiparasitics Revenue Market Share by Region (2026-2031)
 Table 25. North America Antiparasitics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antiparasitics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antiparasitics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antiparasitics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antiparasitics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antiparasitics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antiparasitics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antiparasitics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antiparasitics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antiparasitics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antiparasitics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antiparasitics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antiparasitics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antiparasitics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antiparasitics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antiparasitics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antiparasitics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antiparasitics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antiparasitics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antiparasitics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antiparasitics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antiparasitics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antiparasitics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antiparasitics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antiparasitics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antiparasitics Sales (K Units) by Type (2020-2025)
 Table 51. Global Antiparasitics Sales (K Units) by Type (2026-2031)
 Table 52. Global Antiparasitics Sales Market Share by Type (2020-2025)
 Table 53. Global Antiparasitics Sales Market Share by Type (2026-2031)
 Table 54. Global Antiparasitics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antiparasitics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antiparasitics Revenue Market Share by Type (2020-2025)
 Table 57. Global Antiparasitics Revenue Market Share by Type (2026-2031)
 Table 58. Global Antiparasitics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antiparasitics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antiparasitics Sales (K Units) by Application (2020-2025)
 Table 61. Global Antiparasitics Sales (K Units) by Application (2026-2031)
 Table 62. Global Antiparasitics Sales Market Share by Application (2020-2025)
 Table 63. Global Antiparasitics Sales Market Share by Application (2026-2031)
 Table 64. Global Antiparasitics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antiparasitics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antiparasitics Revenue Market Share by Application (2020-2025)
 Table 67. Global Antiparasitics Revenue Market Share by Application (2026-2031)
 Table 68. Global Antiparasitics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antiparasitics Price (US$/Unit) by Application (2026-2031)
 Table 70. Biosynth Carbosynth Company Information
 Table 71. Biosynth Carbosynth Description and Business Overview
 Table 72. Biosynth Carbosynth Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biosynth Carbosynth Antiparasitics Product
 Table 74. Biosynth Carbosynth Recent Developments/Updates
 Table 75. Dechra Company Information
 Table 76. Dechra Description and Business Overview
 Table 77. Dechra Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Dechra Antiparasitics Product
 Table 79. Dechra Recent Developments/Updates
 Table 80. SANPHAR Company Information
 Table 81. SANPHAR Description and Business Overview
 Table 82. SANPHAR Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. SANPHAR Antiparasitics Product
 Table 84. SANPHAR Recent Developments/Updates
 Table 85. Ipca Laboratories Ltd Company Information
 Table 86. Ipca Laboratories Ltd Description and Business Overview
 Table 87. Ipca Laboratories Ltd Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ipca Laboratories Ltd Antiparasitics Product
 Table 89. Ipca Laboratories Ltd Recent Developments/Updates
 Table 90. Zydus Lifesciences Limited Company Information
 Table 91. Zydus Lifesciences Limited Description and Business Overview
 Table 92. Zydus Lifesciences Limited Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zydus Lifesciences Limited Antiparasitics Product
 Table 94. Zydus Lifesciences Limited Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck Antiparasitics Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Antiparasitics Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. GlaxoSmithKline Plc. Company Information
 Table 106. GlaxoSmithKline Plc. Description and Business Overview
 Table 107. GlaxoSmithKline Plc. Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline Plc. Antiparasitics Product
 Table 109. GlaxoSmithKline Plc. Recent Developments/Updates
 Table 110. Cipla Ltd Company Information
 Table 111. Cipla Ltd Description and Business Overview
 Table 112. Cipla Ltd Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cipla Ltd Antiparasitics Product
 Table 114. Cipla Ltd Recent Developments/Updates
 Table 115. Ranbaxy Laboratories Company Information
 Table 116. Ranbaxy Laboratories Description and Business Overview
 Table 117. Ranbaxy Laboratories Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ranbaxy Laboratories Antiparasitics Product
 Table 119. Ranbaxy Laboratories Recent Developments/Updates
 Table 120. Novartis AG Company Information
 Table 121. Novartis AG Description and Business Overview
 Table 122. Novartis AG Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis AG Antiparasitics Product
 Table 124. Novartis AG Recent Developments/Updates
 Table 125. Alvizia Health Care Company Information
 Table 126. Alvizia Health Care Description and Business Overview
 Table 127. Alvizia Health Care Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Alvizia Health Care Antiparasitics Product
 Table 129. Alvizia Health Care Recent Developments/Updates
 Table 130. Bayer AG Company Information
 Table 131. Bayer AG Description and Business Overview
 Table 132. Bayer AG Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Bayer AG Antiparasitics Product
 Table 134. Bayer AG Recent Developments/Updates
 Table 135. Arbor Pharmaceuticals Inc. Company Information
 Table 136. Arbor Pharmaceuticals Inc. Description and Business Overview
 Table 137. Arbor Pharmaceuticals Inc. Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Arbor Pharmaceuticals Inc. Antiparasitics Product
 Table 139. Arbor Pharmaceuticals Inc. Recent Developments/Updates
 Table 140. Sanofi Company Information
 Table 141. Sanofi Description and Business Overview
 Table 142. Sanofi Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Sanofi Antiparasitics Product
 Table 144. Sanofi Recent Developments/Updates
 Table 145. AstraZeneca Company Information
 Table 146. AstraZeneca Description and Business Overview
 Table 147. AstraZeneca Antiparasitics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. AstraZeneca Antiparasitics Product
 Table 149. AstraZeneca Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Antiparasitics Distributors List
 Table 153. Antiparasitics Customers List
 Table 154. Antiparasitics Market Trends
 Table 155. Antiparasitics Market Drivers
 Table 156. Antiparasitics Market Challenges
 Table 157. Antiparasitics Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antiparasitics
 Figure 2. Global Antiparasitics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiparasitics Market Share by Type: 2024 & 2031
 Figure 4. Injectable Forms Product Picture
 Figure 5. Oral Forms Product Picture
 Figure 6. Global Antiparasitics Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antiparasitics Market Share by Application: 2024 & 2031
 Figure 8. Animal
 Figure 9. Human
 Figure 10. Global Antiparasitics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Antiparasitics Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Antiparasitics Sales (2020-2031) & (K Units)
 Figure 13. Global Antiparasitics Average Price (US$/Unit) & (2020-2031)
 Figure 14. Antiparasitics Report Years Considered
 Figure 15. Antiparasitics Sales Share by Manufacturers in 2024
 Figure 16. Global Antiparasitics Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Antiparasitics Players: Market Share by Revenue in Antiparasitics in 2024
 Figure 18. Antiparasitics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Antiparasitics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Antiparasitics Sales Market Share by Country (2020-2031)
 Figure 21. North America Antiparasitics Revenue Market Share by Country (2020-2031)
 Figure 22. United States Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Antiparasitics Sales Market Share by Country (2020-2031)
 Figure 25. Europe Antiparasitics Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Antiparasitics Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Antiparasitics Revenue Market Share by Region (2020-2031)
 Figure 33. China Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Antiparasitics Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Antiparasitics Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Antiparasitics Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Antiparasitics Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Antiparasitics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Antiparasitics by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Antiparasitics by Type (2020-2031)
 Figure 54. Global Antiparasitics Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Antiparasitics by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Antiparasitics by Application (2020-2031)
 Figure 57. Global Antiparasitics Price (US$/Unit) by Application (2020-2031)
 Figure 58. Antiparasitics Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart